XIN.F Shandong Xinhua Pharmaceutical Company Limited

Healthcare Pharmaceuticals Frankfurt Exchange
4.71 EUR
Close of Nov 12, 2026
0.5474 0.7557
Market cap
EUR 918M
P/E
14.5x
P/B
0.56x
ROE
4.9%
Dividend yield
3.29%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is XIN.F undervalued?

Graham number
Price4.71
Graham value7.81
Discount39.7%

XIN.F trades 39.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shandong Xinhua Pharmaceutical Company Limited fundamental analysis

No fundamental analysis for Shandong Xinhua Pharmaceutical Company Limited yet.

Shandong Xinhua Pharmaceutical Company Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shandong Xinhua Pharmaceutical Company Limited

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generi…

Full company profile